Correlation Between Personnality Traits and Ability to Learn Oroesophageal Voice

NCT ID: NCT06856863

Last Updated: 2025-12-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-14

Study Completion Date

2028-10-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

After total laryngectomy and loss of laryngeal phonation, the oro-oesophageal voice (VOO) is a communication option for the patient. It involves little financial outlay and, when mastered, ensures functional communication, but requires time-consuming speech therapy. VOO acquisition depends on a number of factors, including the patient's physiology, personality and socio-cultural environment. Several authors have suggested the influence of psychology on failure to learn VOO, but the studies found in the literature are old and did not use personality tests to objectivize this link through quantitative analysis. Today, the Temperament and Character Inventory (TCI-125) is a personality test used clinically and in research, and appreciated for the quantitative scores it provides.

The aim of our study is to ascertain whether salient personality traits (as measured by the TCI) are common to patients who succeed in learning VOO, compared with those who do not.

40 subjects who underwent total laryngectomy and had access to speech therapy will be included in this study. A speech assessment with audio recording will be performed and acoustic measurements will be taken. Subjects will also take the TCI-125. Finally, a perceptual evaluation by a jury of experts will categorize the subjects as good or poor speakers.

Inclusion period: 24 months Duration of subject participation: 1 day Total duration: 36 months

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laryngectomy Total Pharyngo-laryngectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study of personality traits in patients able or unable to learn VOO

Group Type EXPERIMENTAL

Test of personality : questionnary

Intervention Type BEHAVIORAL

The questionnary Temperament and Character Inventory (TCI) describes personality through temperament traits governed by the individual's neurobiological systems and predetermined by heredity; and character traits shaped by social and cognitive experience

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Test of personality : questionnary

The questionnary Temperament and Character Inventory (TCI) describes personality through temperament traits governed by the individual's neurobiological systems and predetermined by heredity; and character traits shaped by social and cognitive experience

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women over 18 years of age
* French-speaking patients
* MoCA score ≥ 16/30
* Patients who have undergone laryngectomy or total pharyngo-laryngectomy between 6 months and 5 years of age
* Patients who have agreed to learn VOO
* Patients who began speech therapy to learn VOO no more than five years ago
* Patients who have had access to speech therapy to learn VOO for at least six months (completed or ongoing)
* Patients who have received information about the study and have not expressed their opposition
* Patients who are beneficiaries of or entitled to social security coverage

Exclusion Criteria

* Patients who underwent a laryngectomy or total pharyngolaryngectomy more than 5 years ago
* Patients who did not receive speech therapy to learn OVO postoperatively, or who received less than 6 months of therapy
* Patients with a related condition that prevents them from learning VOO (anatomical or physiological abnormality, esophageal stenosis)
* Patients with a related condition that may be responsible for speech or fluency disorders (developmental, organic, or functional speech and language disorders, stuttering, stammering, fluency disorders, neurological speech disorders)
* Patients with uncorrected hearing loss
* Patients unable to receive informed consent about the ongoing research due to impaired psychological or physical health
* MoCA score \<16/30
* Patients with definite depressive symptoms (HAD-D score ≥ 11)
* Patients in a period of exclusion from another research protocol at the time of collection of the non-opposition.
* Subjects covered by articles L1121-5 to 1121-8 of the French Public Health Code (minors, adults under guardianship or trusteeship, patients deprived of their liberty, pregnant or breast-feeding women, etc.).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique Hopitaux De Marseille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assistance Publique Hopitaux de Marseille

Marseille, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Camille Galant

Role: CONTACT

0491435817 ext. 33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Camille Galant

Role: primary

0491435817 ext. 33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-A00022-47

Identifier Type: OTHER

Identifier Source: secondary_id

RCAPHM25_0002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Voice Telerehabilitation
NCT05747859 COMPLETED